I am a
Home I AM A Search Login

Papers of the Week


2020 Jan 15


BMC Neurol


20


1

Malignant transformation of pleomorphic xanthoastrocytoma and differential diagnosis: case report.

Authors

Watanabe N, Ishikawa E, Kohzuki H, Sakamoto N, Zaboronok A, Matsuda M, Shibuya M, Matsumura A
BMC Neurol. 2020 Jan 15; 20(1):21.
PMID: 31941461.

Abstract

Pleomorphic xanthoastrocytoma (PXA) is a rare astrocytic glioma, characterized by large pleomorphic and frequently multinucleated cells, spindle and lipidized cells, a dense pericellular reticulin network, and numerous eosinophilic granular bodies according to the grade II glial tumor standards of the World Health Organization's (WHO) 2016 guidelines. PXA rarely transforms into anaplastic PXA or glioblastoma (GBM) and anaplastic PXA, classified as WHO grade III, has a more aggressive clinical behavior with poorer prognosis than PXA.